A retrospective study to evaluate efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's diseas
Latest Information Update: 09 Jul 2020
At a glance
- Drugs Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Ustekinumab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
Most Recent Events
- 19 May 2020 Results published in Gasteroenterology in conjunction with Digestive Disease Week 2020
- 29 Apr 2020 New trial record
- 24 Apr 2020 Results published in the Alimentary Pharmacology and Therapeutics